Section 639.Sec. 6.1 - NEW1. Except as otherwise provided in subsection 2, a pharmacist shall comply with the publications adopted by reference in section 5 and all applicable federal and state laws and regulations, including, without limitation, laws and regulations relating to the labeling of prescriptions and keeping records, when prescribing, dispensing and administering drugs approved by the United States Food and Drug Administration for preventing the acquisition of human immunodeficiency virus pursuant to section 1 of Senate Bill No. 325, chapter 492, Statutes of Nevada 2021, at page 3201 (NRS 639.28085) .2. A pharmacist may prescribe, dispense and administer up to a 30-day supply of a drug approved by the United States Food and Drug Administration for preventing the acquisition of human immunodeficiency virus to continue treatment without completing the requirements for laboratory testing prescribed in section 4 or the publications adopted by reference in section 5 if the pharmacist: (a) Makes a good faith effort to obtain and review the laboratory history of the patient;(b) Completes an assessment of the patient;(c) Reviews potential adverse side effects with the patient; and(d) Determines that the benefit of continuing the treatment outweighs the risk of not continuing the treatment.3. A pharmacist who prescribes, dispenses or administers a drug approved by the United States Food and Drug Administration for preventing the acquisition of human immunodeficiency virus pursuant to section 1 of Senate Bill No. 325, chapter 492, Statutes of Nevada 2021, at page 3201 (NRS 639.28085) , must establish and adhere to a plan of care for treatment using the drug. The plan must include, without limitation, support and ongoing assessment as required by the publications adopted by reference in section 5 .Nev. Admin. Code § 639.Sec. 6.1
Added to NAC by Bd. of Pharmacy by R039-21A, eff. 4/11/2022NRS 639.070, section 1 of Senate Bill No. 325, chapter 492, Statutes of Nevada 2021, at page 3201 (NRS 639.28085)